Publications
Research at the Leibniz Institute for Immunology focuses on the development of pioneering immune-cell therapies targeting cancer, autoimmune diseases, and chronic inflammation. While developments in this field are highly relevant within the medical community, they are also of great interest to the wider general public. The LIT has a comprehensive archive of international articles, publications, lectures, and online resources aimed at a variety of audiences. So, whoever you are, if you do not find what you are looking for, please do not hesitate to contact us.
Massoud R, Flossdorf S, Hanke F, Schroeder T, Bethge W, Zeiser R, Pabst C, Wulf G, Sala E, Hilgendorf I, Scheid C, Edinger M, Stolzel F, Blau IW, Stelljes M, Kobbe G, Platzbecker U, Bittenbring JT, Eder M, Fleischhauer K, Burchert A, Schmid C, Kroger N. Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenib. Haematologica. 2026 Mar 5. doi:10.3324/haematol.2025.300176. PMID: 41784041
Magno G, Rejeski K, Rappa G, Stock S, Holzem A, Landwehr M, Seib M, Kutsch N, Mammadova J, Mayer S, Aumann S, Van Ham J, Ringelstein-Harlev S, Velazquez GF, Wurm-Kuczera R, Scholz JK, Greenbaum U, Raj SS, Shouval R, Muller F, Chapuy B, Schmid C, Beyar-Katz O, Vergote VKJ, Poeck H et al. Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3xCD20 bispecific T-cell engagers. Blood Adv. 2026 Mar 10. 10:1675–1686. doi:10.1182/bloodadvances.2025017766. PMID: 41124666
Hindriks E, Bergmann W, Ruiz AM, Zandvliet M, Sijts A, Broere F. Evaluating VEGFR2 as a Target for Anti-Tumour Therapy in Canine Melanoma. Vet Comp Oncol. 2026 Mar. 24:95–104. doi:10.1111/vco.70029. PMID: 41319225
Buchtler S, Fruhauf A, Neumayer S, Schmidbauer K, Talke Y, Winter-Kohler F, Balam S, Landgraf K, Gebhard C, Rehli M, Schlieckau FV, Beck M, Gunther F, Fleck M, Renner K, Mack M. Fibrosis-memory is mediated by IL-3-producing T cells and drives progression of fibrosis. J Clin Invest. 2026 Mar 16. 136doi:10.1172/JCI192095. PMID: 41837289
Frischholz S, Schuster EM, Grotz M, Schulein C, Benz J, Kocher K, Klotz L, Varga S, Hiltner T, Alsalameh R, Esse J, Trager J, Held J, Graw F, Pahle J, Spriewald B, Gattinoni L, Buchholz VR, Drost F, Schubert B, Rothenfusser S, Busch DH, Bogdan C, Schober K. Metabolic quiescence of naive-like memory T cells precedes and maintains antigen-specific T cell memory. Nat Immunol. 2026 Mar. 27:452–462. doi:10.1038/s41590-026-02421-w. PMID: 41735532
Scheller L, Giordano Attianese GMP, Castellanos-Rueda R, Di Roberto RB, Barden M, Triboulet M, Hafezi M, Ash S, Shui S, Cribioli E, Reichenbach P, Maillard J, Marchand A, Georgeon S, Wolf B, Abken H, Reddy S, Correia BE, Irving M. Drug-controlled CAR T cells through the regulation of cell-cell interactions. Nat Chem Biol. 2026 Feb 19. doi:10.1038/s41589-026-02152-x. PMID: 41714721
Kolb S, Diekmann L, Lochert ED, Warmuth L, Ritter J, Weber M, Hoffmann M, List M, Kotlarz D, Serr I, Daniel C, Busch DH, Schmidl C, Schumann K. SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells. bioRxiv. 2026 Feb 16. doi:10.64898/2026.02.13.705474. PMID: 42051317
Ferreira N, Agorku D, Rosa A, Roosz J, Christ L, Anderle N, Kulkarni A, Hussein A, Sayedipour SS, Luna OF, Legler T, Strobel P, Albericio F, Cruz L, Beckhove P, Loskill P, Alves F, Markus MA, Ramos-Gomes F. Advanced Human Immune Cell-Organoid Co-Cultures for Functional Testing of Cancer Nanovaccines. Adv Sci (Weinh). 2026 Feb. 13:e15199. doi:10.1002/advs.202515199. PMID: 41436389
Babl N, Voll F, Martowicz A, Bruss C, Maddaloni M, Schmidl C, Rehli M, Loipfinger S, Strieder N, Gebhard C, Hoffmann P, Singh SM, Sala-Hojman A, Ferretti R, Matos C, Simon M, Brummer C, Schnell A, Hofbauer J, Decking SM, Hau P, Vollmann-Zwerenz A, Dettmer K, Oefner PJ, Althammer M et al. Lactic acid promotes an MDSC-like phenotype via HIF1alpha stabilization with impact on prognosis in renal cell carcinoma. Cancer Lett. 2026 Feb 28. 639:218209. doi:10.1016/j.canlet.2025.218209. PMID: 41371433